50
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Postperfusion lung syndrome: physiopathology and therapeutic options Translated title: Síndrome pós-perfusão pulmonar: fisiopatologia e opções terapêuticas

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Postperfusion lung syndrome is rare but can be lethal. The underlying mechanism remains uncertain but triggering inflammatory cascades have become an accepted etiology. A better understanding of the pathophysiology and the roles of inflammatory mediators in the development of the syndrome is imperative in the determination of therapeutic options and promotion of patients' prognosis and survival. Postperfusion lung syndrome is similar to adult respiratory distress syndrome in clinical features, diagnostic approaches and management strategies. However, the etiologies and predisposing risk factors may differ between each other. The prognosis of the postperfusion lung syndrome can be poorer in comparison to acute respiratory distress syndrome due to the secondary multiple organ failure and triple acid-base imbalance. Current management strategies are focusing on attenuating inflammatory responses and preventing from pulmonary ischemia-reperfusion injury. Choices of cardiopulmonary bypass circuit and apparatus, innovative cardiopulmonary bypass techniques, modified surgical maneuvers and several pharmaceutical agents can be potential preventive strategies for acute lung injury during cardiopulmonary bypass.

          Translated abstract

          Síndrome pós-perfusão pulmonar é rara, mas pode ser letal. O mecanismo subjacente permanece incerto, mas desencadear cascatas inflamatórias tornou-se uma etiologia aceita. É imperativo uma melhor compreensão da fisiopatologia e os papéis de mediadores inflamatórios no desenvolvimento da síndrome na determinação de opções terapêuticas e de promoção do prognóstico e sobrevida dos pacientes. Síndrome pós-perfusão pulmonar é semelhante à síndrome da angústia respiratória do adulto em características clínicas, métodos diagnósticos e estratégias de gestão. No entanto, as etiologias e fatores de risco predisponentes podem ser diferentes entre si. O prognóstico da síndrome pós-perfusão pulmonar pode ser mais pobres em comparação com síndrome da angústia respiratória aguda, devido à falência de múltiplos órgãos secundária e desequilíbrio ácido-base triplo. Estratégias de gestão atuais centram-se em atenuar reações inflamatórias e impedir lesão pulmonar de isquemia-reperfusão. Escolhas do circuito de circulação extracorpórea e aparelhos, técnicas inovadoras de circulação extracorpórea, manobras cirúrgicas modificadas e vários agentes farmacêuticos podem ser potenciais estratégias preventivas para lesão pulmonar aguda durante a circulação extracorpórea.

          Related collections

          Most cited references156

          • Record: found
          • Abstract: found
          • Article: not found

          Prognostic value of extravascular lung water in critically ill patients.

          Measurement of extravascular lung water (EVLW) as a clinical tool for the assessment of pulmonary function has been found to be more appropriate than oxygenation parameters or radiographic techniques. In this study, we analyzed the prognostic value of EVLW in critically ill patients. Retrospective analysis. Operative ICU of a university hospital. We retrospectively analyzed 373 critically ill patients (133 female and 240 male patients; age range, 10 to 89 years; mean +/- SD age, 53 +/- 19 years) who were treated in our ICU between 1996 and 2000. All these patients were hemodynamically monitored by the transpulmonary double-indicator (thermo-dye) dilution technique. Each patient received a femoral artery sheath through which a 4F flexible catheter with an integrated thermistor and fiberoptic was advanced into the infradiaphragmatic aorta. EVLW was calculated using a computer system. For each measurement, 15 to 17 mL of cooled 2% indocyanine green were injected central venously. In our results, maximum EVLW was significantly higher in nonsurvivors (n = 186) than in survivors (n = 187) [median, 14.3 mL/kg vs 10.2 mL/kg, respectively; p < 0.001]. In univariate logistic regression models, EVLW (r(2) = 0.024, p = 0.003) at baseline as well as simplified acute physiology score (SAPS) II (r(2) = 0.135, p < 0.0001) and APACHE (acute physiology and chronic health evaluation) II scores (r(2) = 0.050, p < 0.0001) were significant predictors of mortality. If SAPS II and APACHE II scores are combined, r(2) increases to 0.136, but the improvement over SAPS II alone is not significant. The addition of baseline EVLW further increases r(2) to 0.149 (p = 0.021 for the improvement), indicating that EVLW contributes independently to prognosis. EVLW correlated well with survival (ie, nonsurvivors had significantly higher EVLW values than survivors) and is an independent predictor of prognosis.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            The inflammatory response to cardiopulmonary bypass: part 1--mechanisms of pathogenesis.

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Effect of exogenous surfactant (calfactant) in pediatric acute lung injury: a randomized controlled trial.

              Despite evidence that patients with acute lung injury (ALI) have pulmonary surfactant dysfunction, trials of several surfactant preparations to treat adults with ALI have not been successful. Preliminary studies in children with ALI have shown that instillation of a natural lung surfactant (calfactant) containing high levels of surfactant-specific protein B may be beneficial. To determine if endotracheal instillation of calfactant in infants, children, and adolescents with ALI would shorten the course of respiratory failure. A multicenter, randomized, blinded trial of calfactant compared with placebo in 153 infants, children, and adolescents with respiratory failure from ALI conducted from July 2000 to July 2003. Twenty-one tertiary care pediatric intensive care units participated. Entry criteria included age 1 week to 21 years, enrollment within 48 hours of endotracheal intubation, radiological evidence of bilateral lung disease, and an oxygenation index higher than 7. Premature infants and children with preexisting lung, cardiac, or central nervous system disease were excluded. Treatment with intratracheal instillation of 2 doses of 80 mL/m2 calfactant or an equal volume of air placebo administered 12 hours apart. Ventilator-free days and mortality; secondary outcome measures were hospital course, adverse events, and failure of conventional mechanical ventilation. The calfactant group experienced an acute mean (SD) decrease in oxygenation index from 20 (12.9) to 13.9 (9.6) after 12 hours compared with the placebo group's decrease from 20.5 (14.7) to 15.1 (9.0) (P = .01). Mortality was significantly greater in the placebo group compared with the calfactant group (27/75 vs 15/77; odds ratio, 2.32; 95% confidence interval, 1.15-4.85), although ventilator-free days were not different. More patients in the placebo group did not respond to conventional mechanical ventilation. There were no differences in long-term complications. Calfactant acutely improved oxygenation and significantly decreased mortality in infants, children, and adolescents with ALI although no significant decrease in the course of respiratory failure measured by duration of ventilator therapy, intensive care unit, or hospital stay was observed.
                Bookmark

                Author and article information

                Journal
                Rev Bras Cir Cardiovasc
                Rev Bras Cir Cardiovasc
                Revista Brasileira de Cirurgia Cardiovascular : órgão oficial da Sociedade Brasileira de Cirurgia Cardiovascular
                Sociedade Brasileira de Cirurgia Cardiovascular
                0102-7638
                1678-9741
                Jul-Sep 2014
                Jul-Sep 2014
                : 29
                : 3
                : 414-425
                Affiliations
                [01]The First Hospital of Putian, Teaching Hospital, Fujian Medical University, Putian, China
                Author notes
                Correspondence address: Shi-Min Yuan. Longdejing Street, 389 - Chengxian District. Putian, Fujian Province, People's Republic of China. E-mail: shi_min_yuan@ 123456yahoo.com
                Article
                10.5935/1678-9741.20140071
                4412333
                25372917
                978030c0-d3f7-4ba3-b20b-be408f619fe1

                This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                : 30 March 2014
                : 19 August 2014
                Categories
                Review Articles

                acid-base imbalance,cardiopulmonary bypass,multiple organ failure,respiratory insufficiency,ventilators, mechanical

                Comments

                Comment on this article